Medicinal cannabis at work: your rights and responsibilities

Medicinal cannabis sits awkwardly with workplace drug policies, and patients are often unsure where they stand. This guide sets out the practical landscape. It is general information, not legal or employment advice — for a specific situation, get advice from your union, an employment lawyer or a community law centre.

The core tension

A valid prescription makes your use legal. It does not, by itself, override your employer's health-and-safety obligations or their workplace drug-and-alcohol policy. Many New Zealand workplaces — particularly in transport, construction, aviation, forestry and other safety-sensitive industries — operate drug-testing regimes, and a positive THC test can have consequences even when the cause is a prescribed medicine.

The reason is impairment and safety, not legality. Employers have duties under health-and-safety law to manage risks, and an impaired worker in a safety-sensitive role is a risk regardless of why they are impaired.

Disclosure: a judgement call

Whether and when to tell your employer is a personal decision with real trade-offs.

Reasons to disclose:

• If your role is safety-sensitive or subject to random testing, disclosing in advance lets you and your employer manage it proactively rather than reactively after a positive test.
• It can open the door to reasonable accommodations — adjusted duties, timing of doses, or non-driving tasks.
• It may be required by your employment agreement or your industry's policy.

Reasons for caution:

• Stigma still exists, and disclosure can't be undone.
• Disclosure of a prescription doesn't change your obligation not to be impaired at work.

A middle path many patients take is to discuss it with their prescriber first, get a clear picture of how their product affects function and timing, and then have an informed conversation with their employer or occupational health provider.

Safety-sensitive roles

If you drive, operate machinery, work at heights, or hold a role where impairment could endanger others, treat the issue seriously. CBD-dominant, non-intoxicating products may be more compatible with such roles than THC-predominant ones, and dose timing (for example, evening-only dosing) can keep working hours clear of active effects. But the decision must be made with your prescriber and, ideally, your employer's occupational-health process — not assumed.

Remember too that workplace consequences can flow from the same testing landscape as the roads: a THC-positive test doesn't distinguish "prescribed and used responsibly the night before" from anything else.

Practical steps

• Read your employment agreement and the drug-and-alcohol policy. Know what it says about prescribed medicines, testing and disclosure.
• Talk to your prescriber about your job specifically. Ask about product choice, timing and how long effects (and detectability) last.
• Consider occupational health. Some employers have an occupational-health provider who can manage prescribed-medicine situations confidentially.
• Don't work impaired. This is the non-negotiable line, regardless of prescription status.
• Get advice if there's a dispute. Unions, employment lawyers and community law centres can help if you face disciplinary action.

Letters and documentation

Some clinics provide employer letters confirming a patient is under medical supervision (often for a fee). These can support a workplace conversation, though they don't override safety policies. Keep your prescription and pharmacy-labelled product accessible.

Testing methods and timing

Workplace drug testing in New Zealand commonly uses either oral-fluid (saliva) or urine testing, and the two have very different detection windows. Saliva tends to reflect more recent use; urine can detect cannabis use for much longer, especially in frequent users, because THC metabolites accumulate and clear slowly. This matters because a urine test can return a positive result long after any impairment has passed — meaning a patient who dosed responsibly the previous evening could still test positive at work. Knowing which method your workplace uses helps you and your prescriber think realistically about product choice and timing, though it never changes the underlying rule against being impaired on the job.

Stigma and confidentiality

Many patients worry about how a prescription will be perceived. It's a legitimate concern, and there's no single right answer. Some find that a calm, factual conversation framing cannabis as a prescribed medicine under medical supervision defuses assumptions. Others prefer to involve an occupational-health provider who can manage the information confidentially. What's clear is that the conversation goes better when you can speak to how your treatment is supervised, how it affects your function, and how you manage timing — rather than leaving your employer to fill the gaps with stereotypes.

The honest summary

Being a legal medicinal cannabis patient and being employed in a safety-sensitive role are not automatically in conflict — but reconciling them takes planning, the right product and dose timing, and often an honest conversation. A prescription protects the legality of your use; it does not protect you from the consequences of being impaired at work. Know your policy, involve your prescriber, and get proper advice if a problem arises.

Last reviewed 17 August 2026 — education, not medical, legal or employment advice. For workplace disputes, seek advice from a union, employment lawyer or community law centre. Source: bpacnz.